Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Luteal phase ovarian stimulation with Follitropin delta and dydrogesterone: randomized crossover pilot in oocyte donors
2024-513998-48-00Phase 4Authorised
- Sponsor
- UZ Brussel
- Start
- Jul 2024
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of recombinant human follicle stimulating hormone and dydrogesterone (2 arms), sponsored by UZ Brussel. Primary endpoint: Total number of retrieved COCs. Planned start Jul 2024; status: authorised.
02
Drugs
recombinant human follicle stimulating hormonedydrogesterone
Beyond the preview
Go deeper on 2024-513998-48-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513998-48-00.